This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AtriCure's CEO Discusses Q2 2012 Results - Earnings Call Transcript

AtriCure, Inc. (ATRC)

Q2 2012 Results Earnings Call

August 2, 2012 4:30 PM ET

Executives

David Drachman – President and CEO

Mike Hooven – Co-founder

Dick Johnston – Chairman

Lynn Pieper – IR Consultant

Analysts

Brooks West – Piper Jaffray

Jason Mills – Canaccord Genuity

Danielle Antalffy – Leerink Swann

Matt Dolan – Roth Capital Partners

Charley Jones – Barrington Research

Larry Haimovitch – HMTC

Presentation

Operator

Good morning and welcome to AtriCure's Second Quarter 2012 Earnings Conference Call. My name is Fab and I will be your coordinator for the call today. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session toward the end of today's call. As a reminder, this call is being recorded for replay purposes.

I would now like to turn the call over to Mr. David Drachman, President and Chief Executive Officer of AtriCure. Mr. Drachman, please proceed.

David Drachman

Thank you, Fab. Good morning, and welcome to our second quarter earnings conference call. Joining me on the call today, two members of our Board of Directors, our co-founder Mr. Mike Hooven, and our Chairman Mr. Dick Johnston, as well as Lynn Pieper our Investor Relations Consultant.

I would now like to turn the call over to Lynn, for a few introductory comments.

Lynn Pieper

Thank you, Dave. By now you should have received a copy of the earnings press release. If you've not received a copy, please call 513-755-4136, to have one emailed to you.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs